MX9302312A - PROGESTERONE RECEIVING AGONIST AND ANTAGONIST COMPOUNDS, NON-STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. - Google Patents

PROGESTERONE RECEIVING AGONIST AND ANTAGONIST COMPOUNDS, NON-STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Info

Publication number
MX9302312A
MX9302312A MX9302312A MX9302312A MX9302312A MX 9302312 A MX9302312 A MX 9302312A MX 9302312 A MX9302312 A MX 9302312A MX 9302312 A MX9302312 A MX 9302312A MX 9302312 A MX9302312 A MX 9302312A
Authority
MX
Mexico
Prior art keywords
progesterone
steroids
agonist
receiving
pharmaceutical compositions
Prior art date
Application number
MX9302312A
Other languages
Spanish (es)
Inventor
William Fenical
Todd K Jones
Lawrence G Hamann
Luc Farmer
I Charles Pathirana
Tina S Berger
Robert S Stein
Original Assignee
Ligand Pharm Inc
Univ Ca
Lifornia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ligand Pharm Inc, Univ Ca, Lifornia filed Critical Ligand Pharm Inc
Publication of MX9302312A publication Critical patent/MX9302312A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/24—Halogenated aromatic hydrocarbons with unsaturated side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/603—Unsaturated compounds containing a keto groups being part of a ring of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere compuestos no esteroidales los cuales son ligandos de alta específicidad, de afinidad elevada, para los receptores de progesterona. Los compuestos incluyen derivados sintéticos de ciclomopol y sus diastereómeros, el monometil éter de (3R)-ciclocimopol espectroscópica y cromatográficamente puro, el cual funciona como un antagonista del receptor de la progesterona, y al monometil éter del (3S)-ciclocimopol, espectroscópica y cromatográficamente puro, el cual funciona como un antagonista del receptor de la progesterona.This invention relates to non-steroidal compounds which are high specificity, high affinity ligands for progesterone receptors. Compounds include synthetic derivatives of cyclomopol and its diastereomers, spectroscopically and chromatographically pure (3R) -cyclocycloimopol monomethyl ether, which functions as a progesterone receptor antagonist, and (3S) -cyclocycloimopol monomethyl ether, spectroscopic and chromatographically pure, which functions as a progesterone receptor antagonist.

MX9302312A 1992-04-21 1993-04-21 PROGESTERONE RECEIVING AGONIST AND ANTAGONIST COMPOUNDS, NON-STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. MX9302312A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87271092A 1992-04-21 1992-04-21
US4864693A 1993-04-16 1993-04-16

Publications (1)

Publication Number Publication Date
MX9302312A true MX9302312A (en) 1994-06-30

Family

ID=26726365

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302312A MX9302312A (en) 1992-04-21 1993-04-21 PROGESTERONE RECEIVING AGONIST AND ANTAGONIST COMPOUNDS, NON-STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Country Status (5)

Country Link
EP (1) EP0637296A4 (en)
AU (1) AU4117093A (en)
CA (1) CA2133325A1 (en)
MX (1) MX9302312A (en)
WO (1) WO1993021145A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677336A (en) * 1993-10-21 1997-10-14 Ligand Pharmaceuticals Incorporated Non-steroid androgen receptor antagonist compounds and methods
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
WO2020205867A1 (en) 2019-04-02 2020-10-08 Aligos Therapeutics, Inc. Compounds targeting prmt5

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491172A (en) * 1967-02-10 1970-05-31 Sandoz Ag Process for the preparation of anthraquinone dyes
US5135940A (en) * 1982-09-23 1992-08-04 Merck Frosst Canada, Inc. Leukotriene antagonists
JPS6287556A (en) * 1985-10-14 1987-04-22 Chisso Corp Ester compound
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5017610A (en) * 1988-06-13 1991-05-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-substituted phenyl ester of pivalic acid
DE3903988A1 (en) * 1989-02-10 1990-08-30 Basf Ag OXIDIZED DIPHENYLHETEROALKANES, THEIR PREPARATION AND USE
US5134155A (en) * 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors

Also Published As

Publication number Publication date
AU4117093A (en) 1993-11-18
CA2133325A1 (en) 1993-10-28
EP0637296A4 (en) 1996-02-07
WO1993021145A1 (en) 1993-10-28
EP0637296A1 (en) 1995-02-08

Similar Documents

Publication Publication Date Title
HN1998000157A (en) PROSTAGLANDIN AGONISTS
ES2175350T3 (en) TRICICLIC COMPOUNDS THAT HAVE AFFINITY OF UNION TO MELATONINE RECEPTORS, THEIR PRODUCTION AND USE.
PA8550401A1 (en) FUSIONED BICYCLE HETEROARILO COMPOUNDS SUBSTITUTED WITH HETEROARILO AS BINDING OF GABA RECEIVER
GT199900070A (en) DERIVATIVES OF ISOTIAZOLE, USEFUL AS ANTI-CANCER AGENTS.
YU34898A (en) Ccr-3 receptor antagonists
EA200200646A1 (en) UREA COMPOUNDS WITH ANTAGONIST MUSCARINE RECEPTOR ACTIVITY
EA200101177A1 (en) INDOL DERIVATIVES AS PROGESTERONE ANTAGONISTS
PT800519E (en) STEROID RECEPTOR MODULATORS AND METHODS
ES2151652T3 (en) DERIVATIVES OF INDOL AS ANTAGONISTS OF THE 5HT RECEIVER.
ES2154674T3 (en) DERIVATIVES OF 1,5-BENZODIACEPINS WITH ANTAGONIST OR AGONIST ACTIVITY OF CCK.
ES2060026T3 (en) 1H-IMIDAZO (4,5-C) QUINOLIN-4-OLEFINIC AMINES.
EA199900581A1 (en) DERIVATIVES INDANA OR DIHYDROINDOLA
ECSP034428A (en) CYCLOPENTHANOLS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND THEIR USE
ES2153907T3 (en) SPRAY TETRACICLIC COMPOUNDS, PROCEDURE FOR PREPARATION AND USE AS ANTAGONIST OF THE 5HT1D RECEIVER.
UY25794A1 (en) PROCEDURE FOR THE PREPARATION OF ADENINE-DERIVED COMPOUNDS, WHICH ARE ADENOSINE A2A RECEPTOR AGONISTS
ES2054872T3 (en) NEW DERIVATIVES OF BENCIMIDAZOLIN-2-OXO-1-CARBOXYLIC ACID USEFUL AS ANTAGONISTS OF 5-HT RECEPTORS.
UY26199A1 (en) NEW BENZENE DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
AR002268A1 (en) BENZACEPINE TRICYCLIC VASOPRESIN ANTAGONISTS, A PROCEDURE FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF SUCH COMPOUNDS TO PREPARE PHARMACEUTICAL COMPOSITIONS.
MX9400255A (en) ANALOGS OF OPIOID PEPTIDES, METHOD FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM.
UY24569A1 (en) BENZOXAZINONE DOPAMINE D4 RECEPTOR ANTAGONISTS
Raub et al. The piclavines, antimicrobial indolizidines from the tunicate Clavelina picta
ES2161718T3 (en) 2,5-DIOXO-2,5-DIHIDRO-1H-BENZO (B) AZEPINAS AS ANTAGONISTS OF NMDA RECEPTORS.
MX9302312A (en) PROGESTERONE RECEIVING AGONIST AND ANTAGONIST COMPOUNDS, NON-STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MX9300602A (en) BOMBESIN PHENYLALANINE ANALOGS.
ES2152682T3 (en) INDOLINA DERIVATIVES USEFUL AS ANTAGONISTS OF THE 5HT-2C RECEIVER.